Vector VestAdvertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator, KingDMC
Search This Board:
Last Post: 1/26/2015 9:12:39 PM - Followers: 384 - Board type: Free - Posts Today: 0

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
INO News: Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers 12/18/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology 12/17/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 12/15/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bac... 10/21/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Vice President of Commercial Development 09/30/2014 07:00:00 AM
News News Alert: Investment Industry to Gather in Philadelphia at 22nd Annual Groundhog Day Investment Forum 01/29/2015 12:05:00 PM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#12733   There's a very good chance that could have future1 01/26/15 09:12:38 PM
#12732   Did anyone see that 172K buy @ $8.88? Tate 01/26/15 04:49:14 PM
#12731   Crap! Should have sold my 8.18s when it cracity 01/22/15 12:26:57 PM
#12730   If you are wanting to stay up on Autumnforest 01/20/15 05:39:48 PM
#12729   I'm not on FB i was just wondering celtic 01/20/15 02:20:01 PM
#12728   Well said guys. I think 2015 will be biovalidator 01/20/15 02:15:37 PM
#12727   Yes. The redhead. Autumnforest 01/19/15 07:24:43 PM
#12726   2013 was a very good year for INO shareholders. pistol1p 01/17/15 01:30:58 AM
#12725   Are you on FB autumn? celtic 01/16/15 09:01:13 AM
#12724   Most folks went over to Facebook to the Autumnforest 01/15/15 09:19:49 PM
#12723   What happened to Everywhereman? I wonder what his Peterconway13 01/15/15 09:09:46 PM
#12722   There was a time this board was popping. KingDMC 01/14/15 06:07:05 PM
#12721   That is actually one of the things that future1 01/14/15 04:29:43 PM
#12720   Such a quiet board for a platform co. Adi2 01/14/15 03:19:11 PM
#12719   Video-Corporate Presentation - January 2015 for Inovio Pharmaceuticals Inc. htt MRatt 01/13/15 12:31:26 AM
#12718   Inovio Pharmaceuticals Given a $20.00 Price Target at nanopatent 01/07/15 09:27:43 AM
#12717   Just doing my DD! nanopatent 01/06/15 01:23:22 PM
#12715   INO is worth $100/sh on this alone! nanopatent 01/06/15 09:06:21 AM
#12714   News! MRatt 01/06/15 08:29:53 AM
#12713   Thanks! ringao 01/03/15 09:57:07 AM
#12712   2015 should be a good year. We will biovalidator 01/02/15 09:23:51 PM
#12711   Go INO in 2015 Reindeer830 01/01/15 01:51:49 PM
#12710   INO Chart conix 12/31/14 02:03:12 PM
#12709   Maxim Group started coverage on shares of Inovio nanopatent 12/25/14 09:55:47 AM
#12708   Pr dropped at 2:50 pm central time. Future2016 12/21/14 02:39:19 AM
#12707   Just index funds rebalancing. Check any other bio ImaPseudonym 12/20/14 01:38:34 PM
#12706   What exactly happened in the last 20 minutes aborou 12/20/14 01:30:40 PM
#12705   * * $INO Video Chart 12-19-14 * * ClayTrader 12/19/14 05:01:22 PM
#12704   Go Baby Go! cracity 12/18/14 10:57:19 AM
#12703   Very nice KingDMC 12/18/14 09:05:08 AM
#12702   News! Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for MRatt 12/18/14 08:15:36 AM
#12701   Agreed. KingDMC 12/17/14 02:57:33 PM
#12700   A solid add to the Team today.The newest biovalidator 12/17/14 12:33:03 PM
#12699   Liking those buys now. Bounced off those lows, cracity 12/12/14 01:14:32 PM
#12698   Nibbling here at 8.18. That's close to the cracity 12/09/14 09:36:48 AM
#12697   Inovio's science even further validated by the 60 MountainMom 12/07/14 07:59:16 PM
#12696   Why Inovio Pharmaceuticals (INO) Stock Might be a nanopatent 12/07/14 04:01:26 PM
#12695   * * $INO Video Chart 12-04-14 * * ClayTrader 12/04/14 05:49:04 PM
#12694   Lurking and looking to buy at low PPS here. cracity 12/04/14 04:16:58 PM
#12693   Back in free fall: why? ppnlf 12/04/14 01:49:10 PM
#12692   Here's my guess. INO trades much more on ringao 12/02/14 08:27:28 AM
#12691   In the last 7 months, since the R\S, pistol1p 12/02/14 02:39:26 AM
#12690   He did a fine job and I was Autumnforest 11/24/14 05:40:53 PM
#12689   I thought Dr. Kim answered the questions posed north40000 11/24/14 05:36:57 PM
#12688   INO CEO to appear on FASTMONEY tonite 5pm Lolaspike 11/24/14 04:56:19 PM
#12687   I agree and GL to you guys too. biovalidator 11/23/14 08:34:17 PM
#12686   * * $INO Video Chart 11-21-14 * * ClayTrader 11/21/14 05:07:13 PM
#12685   INO is definitely a long term investment. pistol1p 11/20/14 09:47:53 PM
#12684   Kim said 3100 est. commercial avail 2017. Imaginaryharry 11/20/14 01:49:36 PM
#12683   When will they start to sell product and Paulness 11/20/14 01:16:07 PM